Details for Australian Trade Mark No. 1068407 (hide)

Owner AnorMed Inc.

Convention CA 15 FEBRUARY 2005 1,247,380

Service Phillips Ormonde Fitzpatrick

Various Convention priority claimed: 15 February 2005, Canada, No. 1,247,380 in respect of PHARMACEUTICAL AND MEDICINAL PREPARATIONS FOR THE TREATMENT OF HIV, INFLAMMATION, ARTHRITIS, ASTHMA, CANCER, CELL TRANSPLANTS AND CELL TRANSPLANT REJECTION, ORGAN TRANSPLAN

Filing Date 4 August 2005

Classes

Class 5 Pharmaceutical and medicinal preparations, including preparations for the treatment of HIV, inflammation, arthritis, asthma, cancer, cell transplants and cell transplant rejection, organ transplants and organ transplant rejection, angiogenesis, multiple sclerosis, bacterial infection, peripheral blood stem cell mobilization, cardiovascular diseases, lymphoma, tissue regeneration, tissue repair, leukemia, drug-induced anemia, retrovirus, hematopoietic deficit resulting from chemotherapy or radiation therapy, elevation of white blood cells, and ophthalmic diseases, including age related macular degeneration and diabetic retinopathy

Event Publications

25 August 2005 Application filed

25 August 2005 Application Accepted

25 August 2005 Trade Mark Removed from the Register / IR Expired

22 December 2005 Trade Mark Registered/Protected

17 January 2008 Subsequent Owners/Holder Registered - Full Assignment

  AnorMed Inc. is the full asignee of Genzyme Corporation.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1068408-ARMONIOSO

1068406-AIRENRACE